Alonso, Silvia PatriciaValdes, SergioMaldonado-Araque, CristinaLago, AnaOcon, PilarCalle, AlfonsoCastaño, LuisDelgado, EliasMenendez, EdelmiroFranch-Nadal, JosepGaztambide, SoniaGirbes, JuanChaves, FelipeGarcia-Serrano, SaraGarcia-Escobar, EvaFernandez-Garcia, Jose CarlosOlveira, GabrielColomo, NataliaRojo-Martinez, Gemma2023-05-032023-05-032021-11-04Alonso SP, Valdés S, Maldonado-Araque C, Lago A, Ocon P, Calle A, et al. Thyroid hormone resistance index and mortality in euthyroid subjects: Di@bet.es study. Eur J Endocrinol. 2021 Dec 1;186(1):95-103http://hdl.handle.net/10668/20443It has been proposed that a mild form of acquired resistance to thyroid hormone may occur in the general population. Its clinical significance remains largely unknown. The objective of the study was to explore whether a newly described thyroid hormone resistance index is associated with the risk of mortality in a sample of community-dwelling euthyroid subjects representative of the adult population of Spain. Longitudinal observational study including 3750 individuals, free of thyroid disease, TPO antibodies-negative ( We used the Thyroid Feedback Quantile-based Index (TFQI) as a marker of resistance to thyroid hormone. The study population was grouped into categories according to their TFQI values at baseline. Fatal events were ascertained from the national death registry (end of follow-up December 2016). A total of 231 deaths were recorded during an average follow-up of 7.3 years. Compared with the category with the highest sensitivity to free thyroxine (TFQI ≤ p5) (reference), the relative risk of mortality in the categories with TFQI > p5 and ≤p25; >p25 and ≤p50; >p50 and ≤p75; >p75 and ≤p95 and >p95 were 1.01, (0.47-2.19), 1.42 (0.68-2.97), 1.54 (0.74-3.22), 1.47 (0.70-3.11) and 2.61 (1.16-5.89), respectively (P for trend 0.003). The association remained significant after multivariate adjustment of the data (P for trend 0.017). A thyroid hormone resistance index focused on deviations of the average pituitary response to thyroid hormones may be associated with all-cause mortality independently of other conventional risk factors and comorbidities.enRisk FactorsSpainThyroid Function TestsThyroid Hormone Resistance SyndromeYoung AdultAdolescentAdultAgedAged, 80 and overAsymptomatic DiseasesComorbidityFemaleHealth Status IndicatorsHumansIndependent LivingLongitudinal StudiesMaleMiddle AgedPatient Acuityresearch article34735370Restricted AccessHormonas tiroideasMortalidadSíndrome de resistencia a hormonas tiroideasRetroalimentaciónCaracterísticas de la residenciaEnfermedades de la tiroides10.1530/EJE-21-06401479-683Xhttps://eje.bioscientifica.com/downloadpdf/journals/eje/186/1/EJE-21-0640.pdf